Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 11, 2009
Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa
Amy L Pakyz, Michael Oinonen, Ronald E Polk
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 19, 2011
Antifungal use in hospitalized adults in U.S. academic health centers
Amy L Pakyz, Holly E Gurgle, Michael J Oinonen
American Journal of Infection Control
|
August 1, 2017
Associations between antimicrobial stewardship program elements and Clostridium difficile infection performance
Giulia Barlow, Julie Patterson, Jeremy Stultz, et al.
Archives of Internal Medicine
|
November 13, 2008
Trends in antibacterial use in US academic health centers: 2002 to 2006
Amy L Pakyz, Conan MacDougall, Michael Oinonen, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2013
Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres
Amy L Pakyz, Rachel Jawahar, Qin Wang, et al.
American Journal of Pharmaceutical Education
|
November 15, 2018
Learning Activities to Build Population Health Management Skills for Pharmacy Students
Amy L Pakyz, Kai I Cheang, Jeremy S Stultz, et al.
IISE Transactions on Healthcare Systems Engineering
|
May 18, 2019
Identifying Hospital Antimicrobial Resistance Targets via Robust Ranking
J Paul Brooks, José H Dulá, Amy L Pakyz, et al.
Infection Control and Hospital Epidemiology
|
April 22, 2016
Association Between High-Risk Medication Usage and Healthcare Facility-Onset C. difficile Infection
Julie A Patterson, Michael B Edmond, Samuel F Hohmann, et al.
American Journal of Infection Control
|
March 6, 2016
Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience
Amy L Pakyz, Leticia R Moczygemba, Lynn M VanderWielen, et al.
Clinical Therapeutics
|
July 10, 2016
Antimicrobial Stewardship Program Members' Perspectives on Program Goals and National Metrics
Jacob Van Parys, Michael P Stevens, Leticia R Moczygemba, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
March 11, 2009
Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa
Amy L Pakyz, Michael Oinonen, Ronald E Polk
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 19, 2011
Antifungal use in hospitalized adults in U.S. academic health centers
Amy L Pakyz, Holly E Gurgle, Michael J Oinonen
American Journal of Infection Control
|
August 1, 2017
Associations between antimicrobial stewardship program elements and Clostridium difficile infection performance
Giulia Barlow, Julie Patterson, Jeremy Stultz, et al.
Archives of Internal Medicine
|
November 13, 2008
Trends in antibacterial use in US academic health centers: 2002 to 2006
Amy L Pakyz, Conan MacDougall, Michael Oinonen, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2013
Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres
Amy L Pakyz, Rachel Jawahar, Qin Wang, et al.
American Journal of Pharmaceutical Education
|
November 15, 2018
Learning Activities to Build Population Health Management Skills for Pharmacy Students
Amy L Pakyz, Kai I Cheang, Jeremy S Stultz, et al.
IISE Transactions on Healthcare Systems Engineering
|
May 18, 2019
Identifying Hospital Antimicrobial Resistance Targets via Robust Ranking
J Paul Brooks, José H Dulá, Amy L Pakyz, et al.
Infection Control and Hospital Epidemiology
|
April 22, 2016
Association Between High-Risk Medication Usage and Healthcare Facility-Onset C. difficile Infection
Julie A Patterson, Michael B Edmond, Samuel F Hohmann, et al.
American Journal of Infection Control
|
March 6, 2016
Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience
Amy L Pakyz, Leticia R Moczygemba, Lynn M VanderWielen, et al.
Clinical Therapeutics
|
July 10, 2016
Antimicrobial Stewardship Program Members' Perspectives on Program Goals and National Metrics
Jacob Van Parys, Michael P Stevens, Leticia R Moczygemba, et al.
Page
of 4